Patents Assigned to HEDGEPATH, LLC.
  • Publication number: 20140315920
    Abstract: The present invention concerns methods for treating a proliferation disorder, such as prostate cancer, basal cell carcinoma, lung cancer, and other cancers, using an inhibitor of the Hedgehog pathway (HhP); and methods for monitoring subjects undergoing such treatments based on biomarkers and other criteria predictive of efficacy.
    Type: Application
    Filed: February 5, 2014
    Publication date: October 23, 2014
    Applicant: HEDGEPATH, LLC.
    Inventors: NICHOLAS J. VIRCA, FRANCIS E. O'DONNELL, JR.